MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $434,760 | -36.3% | 2,977 | +0.7% | 0.00% | -50.0% |
| Q2 2023 | $682,605 | +2.2% | 2,955 | +7.2% | 0.00% | 0.0% |
| Q1 2023 | $667,669 | -24.7% | 2,756 | -9.7% | 0.00% | -33.3% |
| Q4 2022 | $886,133 | +126.6% | 3,053 | -23.2% | 0.00% | +200.0% |
| Q1 2022 | $391,000 | -7.3% | 3,976 | -20.1% | 0.00% | 0.0% |
| Q4 2021 | $422,000 | +5.8% | 4,979 | -0.4% | 0.00% | 0.0% |
| Q3 2021 | $399,000 | -30.8% | 4,999 | -15.6% | 0.00% | -50.0% |
| Q2 2021 | $577,000 | +8.5% | 5,926 | +30.2% | 0.00% | 0.0% |
| Q1 2021 | $532,000 | +10.6% | 4,552 | +5.2% | 0.00% | 0.0% |
| Q4 2020 | $481,000 | +96.3% | 4,326 | +278.8% | 0.00% | 0.0% |
| Q3 2018 | $245,000 | +14.5% | 1,142 | +49.1% | 0.00% | +100.0% |
| Q2 2018 | $214,000 | – | 766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |